For: | Cuadrado A, San Segundo D, López-Hoyos M, Crespo J, Fábrega E. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation. World J Gastroenterol 2015; 21(39): 11016-11026 [PMID: PMC4607901 DOI: 10.3748/wjg.v21.i39.11016] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i39/11016.htm |
Number | Citing Articles |
1 |
Claudia Mescoli, Laura Albertoni, Anthony Jake Demetris. Textbook of Liver Transplantation. 2022; : 319 doi: 10.1007/978-3-030-82930-8_18
|
2 |
C.M. Lin, R.J. Plenter, M. Coulombe, R.G. Gill. Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell–Mediated Antibody-dependent Chronic Rejection. American Journal of Transplantation 2016; 16(11): 3121 doi: 10.1111/ajt.13865
|
3 |
Bejan Sultani, Matthias Marget, Andrea Briem‐Richter, Jochen Herrmann, Sebastian Meisner, Enke Freya Grabhorn, Ann‐Kathrin Ozga, Sören Weidemann, Uta Herden, Lutz Fischer, Martina Sterneck. Presence of donor specific HLA class 2 antibodies (DSA class 2) is associated with development of graft fibrosis more than 10 years after liver transplantation–a retrospective single center study. Clinical Transplantation 2021; 35(7) doi: 10.1111/ctr.14336
|
4 |
Manuel Muro, Isabel Legaz. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation. World Journal of Gastroenterology 2023; 29(5): 766-772 doi: 10.3748/wjg.v29.i5.766
|
5 |
Emma Monique Saelens, Stephanie Van Biervliet, Saskia Vande Velde, Myriam Van Winckel, Xavier Rogiers, Aude Vanlander, Liesbeth Daniëls, Carolien Bonroy, Ruth M.L. De Bruyne. Autoantibodies and Donor-specific Antibodies are Associated With Graft Dysfunction in Pediatric Liver Transplantation. Journal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 661 doi: 10.1097/MPG.0000000000002913
|
6 |
Yi-Ping Jin, Nicole M. Valenzuela, Xiaohai Zhang, Enrique Rozengurt, Elaine F. Reed. HLA Class II–Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection. The Journal of Immunology 2018; 200(7): 2372 doi: 10.4049/jimmunol.1701259
|
7 |
M.-W. Welker, A. A. Schnitzbauer. Aktuelle Aspekte der Immunsuppression nach Transplantation solider Organe. Der Gastroenterologe 2019; 14(4): 289 doi: 10.1007/s11377-019-0357-y
|
8 |
Carme Baliellas, Laura Lladó, Teresa Serrano, Emma Gonzalez-Vilatarsana, Alba Cachero, Josefina Lopez-Dominguez, Anna Petit, Joan Fabregat. Sinusoidal obstruction syndrome as a manifestation of acute antibody-mediated rejection after liver transplantation. American Journal of Transplantation 2021; 21(11): 3775 doi: 10.1111/ajt.16689
|
9 |
Michelle Bräutigam, Thomas Volken, Alexandra Plattner, Jakob R. Passweg, Jörg P. Halter, Beatrice Drexler, Dominik Heim, Stefan Schaub, Andreas S. Buser, Laura Infanti, Andreas Holbro. Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation. Transfusion and Apheresis Science 2022; 61(2): 103301 doi: 10.1016/j.transci.2021.103301
|
10 |
Kenei Furukawa, Koichiro Haruki, Mureo Kasahara, Tomohiko Taniai, Toru Ikegami. Dual Antibody Treatment for Simultaneous Acute Cellular Rejection and Antibody-Mediated Rejection After Liver Transplantation: A Case Report. Transplantation Proceedings 2023; 55(8): 1938 doi: 10.1016/j.transproceed.2023.03.093
|
11 |
Dominique Schluckebier, Vladimir L. Cousin, Laetitia‐Marie Petit, Dominique Belli, Barbara Wildhaber, Anne‐Laure Rougemont, Jean Villard, Sylvie Ferrari‐Lacraz, Valérie A. McLin. Preformed and de novo DSA are associated with T‐cell–mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy. Pediatric Transplantation 2020; 24(1) doi: 10.1111/petr.13611
|
12 |
Nobuhisa Akamatsu, Kiyoshi Hasegawa, Seisuke Sakamoto, Hideki Ohdan, Ken Nakagawa, Hiroto Egawa. Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey. Transplantation Direct 2021; 7(8): e729 doi: 10.1097/TXD.0000000000001180
|
13 |
Vadim Jucaud, Abraham Shaked, Michele DesMarais, Peter Sayre, Sandy Feng, Josh Levitsky, Matthew J. Everly. Prevalence and Impact of De Novo Donor‐Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients. Hepatology 2019; 69(3): 1273 doi: 10.1002/hep.30281
|
14 |
Jérôme Dumortier, Filomena Conti, Jean-Baptiste Hiriart, Sébastien Dharancy, Christophe Duvoux, Camille Besch, Pauline Houssel-Debry, Marianne Latournerie, Faiza Chermak, Magdalena Meszaros, Georges-Philippe Pageaux, Sylvie Radenne, Olivier Boillot, Jean Hardwigsen, Ilias Kounis, Nassim Kamar, Faouzi Saliba, Domitille Erard, Arnaud Del Bello. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study. Liver Transplantation 2023; doi: 10.1097/LVT.0000000000000200
|
15 |
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantation. Portal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
|
16 |
Zahra Beyzaei, Bita Geramizadeh, Zahra Bagheri, Sara Karimzadeh, Alireza Shojazadeh. De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.613128
|
17 |
Martin-Walter Welker, Andreas A. A. Schnitzbauer. Aktuelle Aspekte der Immunsuppression nach Transplantation solider Organe. Wiener klinisches Magazin 2019; 22(6): 272 doi: 10.1007/s00740-019-00315-2
|
18 |
Yoshihiro Hirata, Atsushi Yoshizawa, Hiroto Egawa, Daisuke Ueda, Shinya Okamoto, Hideaki Okajima, Kimiko Yurugi, Rie Hishida, Hideyo Hirai, Aya Miyagawa-Hayashino, Taira Maekawa, Hironori Haga, Sinji Uemoto. Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis. Transplantation 2017; 101(5): 1074 doi: 10.1097/TP.0000000000001653
|
19 |
Henry Sutanto, Ummi Maimunah, Deasy Fetarayani. Donor-specific antibodies and their impact on antibody-mediated rejection post-liver transplantation: A comprehensive review. Journal of Liver Transplantation 2024; 14: 100214 doi: 10.1016/j.liver.2024.100214
|
20 |
Jennifer A. McCaughan, Victoria Robertson, Stuart J. Falconer, Claire Cryer, David M. Turner, Gabriel C. Oniscu. Preformed donor‐specific HLA antibodies are associated with increased risk of early mortality after liver transplantation. Clinical Transplantation 2016; 30(12): 1538 doi: 10.1111/ctr.12851
|
21 |
Anna Mariani, Matteo Tripepi, Iacopo Mangoni, Paolo Aseni. The High-risk Surgical Patient. 2023; : 551 doi: 10.1007/978-3-031-17273-1_50
|
22 |
Andrew D. Clouston, Stefan G. Hübscher. MacSween's Pathology of the Liver. 2024; : 947 doi: 10.1016/B978-0-7020-8228-3.00014-4
|
23 |
Andrew D. Clouston, Stefan G. Hübscher. Macsween's Pathology of the Liver. 2018; : 880 doi: 10.1016/B978-0-7020-6697-9.00014-5
|
24 |
Manuel Arias, Daniel Serón, Ignacio Herrero, David N. Rush, Chris Wiebe, Peter W. Nickerson, Piedad Ussetti, Emilio Rodrigo, Maria-Angeles de Cos. Subclinical Antibody-Mediated Rejection. Transplantation 2017; 101(6S): S1 doi: 10.1097/TP.0000000000001735
|
25 |
Manuel Muro. The endless history or search for the true role of alloantibodies in liver transplantation. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101544 doi: 10.1016/j.clinre.2020.09.005
|
26 |
Nicole M. Valenzuela, Michelle J. Hickey, Elaine F. Reed. Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Frontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00433
|
27 |
Hyeyoung Kim, Nam‐Joon Yi, Eun Young Song, Kyoungbun Lee, Kwang‐Woong Lee, Hae Won Lee, Hye Young Ahn, Kyung Chul Yoon, Suk Kyun Hong, Kyung‐Suk Suh. Preformed donor‐specific antibodies do not affect the 1‐year allograft survival in living donor liver transplantation. Clinical Transplantation 2018; 32(5) doi: 10.1111/ctr.13244
|
28 |
D. San Segundo, C. Alonso, P. Ruiz, I. Roman, M.T. Arias-Loste, A. Cuadrado, A. Puente, F. Casafont, M. López-Hoyos, J. Crespo, E. Fábrega. De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver Transplantation. Transplantation Proceedings 2016; 48(9): 2980 doi: 10.1016/j.transproceed.2016.08.037
|
29 |
Taichi Arai, Hideyo Oguchi, Kazunobu Shinoda, Kei Sakurabayashi, Tetuo Mikami, Yoshihiro Itabashi, Ken Sakai. Clinicopathological Analysis of Acute/Active Antibody-Mediated Rejection in Renal Allografts According to the Banff 2013 Classification. Nephron 2020; 144(Suppl. 1): 18 doi: 10.1159/000512143
|
30 |
Jin Wang, Ping Wang, Shuiliang Wang, Jianming Tan. Donor-specific HLA Antibodies in Solid Organ Transplantation: Clinical Relevance and Debates. Exploratory Research and Hypothesis in Medicine 2019; 0(000): 1 doi: 10.14218/ERHM.2019.00012
|
31 |
Savio G. Barreto, Mark E. Brooke-Smith, Eu Ling Neo, Paul Dolan, Richard Leibbrandt, Tim Emery, Robert Carroll, Alan Wigg, John W. Chen. Exploring pre-surgery donor-specific antibodies in the context of organ shortage in liver transplant. Langenbeck's Archives of Surgery 2019; 404(7): 865 doi: 10.1007/s00423-019-01831-9
|
32 |
Yuanyi Mang, Yang Gao, Yan Yang, Mei Dong, Qian Yang, Hong Li, Jianghua Ran, Li Li, Jun Ma, Guoyu Chen, Bin Yang, Ying Xie, Yunsong Wu, Yingpeng Zhao, Shengning Zhang. Experience on AMR Diagnosis and Treatment Following Liver Transplantation: Case Series. Transplantation Direct 2024; 10(4): e1598 doi: 10.1097/TXD.0000000000001598
|
33 |
Ming-Li Yin, Hong-Li Song, Yang Yang, Wei-Ping Zheng, Tao Liu, Zhong-Yang Shen. Effect of <i>CXCR3/HO-1</i> genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection. World Journal of Gastroenterology 2017; 23(22): 4016-4038 doi: 10.3748/wjg.v23.i22.4016
|